$PRSI
PORTSMOUTH SQUARE INC Stock $prsi

$prsi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224006479 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$10.76M	$10.23M	$9.892M
YoY Change	3.14%	3.37%	55.83%
Cost Of Revenue	$9.239M	$9.405M	$8.726M
YoY Change	9.82%	7.78%	34.68%
Gross Profit	$1.519M	$820.0K	$1.166M
YoY Change	-24.69%	-29.67%	-990.08%
Gross Profit Margin	14.12%	8.02%	11.79%
Selling, General & Admin	$301.0K	$434.0K	$517.0K
YoY Change	-39.31%	-16.05%	83.33%
% of Gross Profit	19.82%	52.93%	44.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$860.0K	$842.0K	$716.0K
YoY Change	24.1%	17.6%	22.6%
% of Gross Profit	56.62%	102.68%	61.41%
Operating Expenses	-$9.540M	-$9.839M	-$9.243M
YoY Change	7.08%	6.45%	-1261.18%
Operating Profit	$358.0K	-$455.0K	$14.00K
YoY Change	-56.76%	-3350.0%	-101.51%
Interest Expense	-$3.189M	-$2.067M	-$1.971M
YoY Change	58.81%	4.87%	-15.73%
% of Operating Profit	-890.78%		-14078.57%
Other Income/Expense, Net	-$3.229M	-$2.111M	-$2.052M
YoY Change	53.98%	2.88%	3846.15%
Pretax Income	-$2.871M	-$2.566M	-$2.038M
YoY Change	126.24%	25.91%	52.32%
Income Tax			-$718.0K
% Of Pretax Income
Net Earnings	-$2.871M	-$2.566M	-$1.320M
YoY Change	171.62%	94.39%	37.5%
Net Earnings / Revenue	-26.69%	-25.1%	-13.34%
Basic Earnings Per Share	-$3.91	-$3.50	-$1.80
Diluted Earnings Per Share	-$3.91	-$3.50	-$1.80
COMMON SHARES
Basic Shares Outstanding	734.2K shares	734.2K shares	734.2K shares
Diluted Shares Outstanding	734.2K shares	734.2K shares	734.2K shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.885M	$3.993M	$1.538M
YoY Change	179.7%	159.62%	434.03%
Cash & Equivalents	$3.572M	$3.668M	$1.236M
Short-Term Investments	$313.0K	$325.0K	$302.0K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$459.0K	$447.0K	$324.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.031M	$4.115M	$1.560M
YoY Change	203.77%	163.78%	208.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$34.51M	$34.64M	$32.65M
YoY Change	3.3%	6.09%	2.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$313.0K	$325.0K	$302.0K
YoY Change	-21.75%	7.62%	-79.07%
Other Assets	$1.637M	$800.0K	$12.70M
YoY Change	-85.92%	-93.7%	-19.36%
Total Long-Term Assets	$37.62M	$36.74M	$47.45M
YoY Change	-21.35%	-22.56%	-5.03%
TOTAL ASSETS
Total Short-Term Assets	$4.031M	$4.115M	$1.560M
Total Long-Term Assets	$37.62M	$36.74M	$47.45M
Total Assets	$41.66M	$40.86M	$49.01M
YoY Change	-15.27%	-16.63%	-2.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.12M	$13.45M	$8.140M
YoY Change	19.96%	65.18%	-0.77%
Accrued Expenses	$6.501M	$4.821M	$3.290M
YoY Change	49.14%	46.53%	9.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due			$77.00K
YoY Change			-69.08%
Total Short-Term Liabilities	$23.61M	$21.24M	$15.44M
YoY Change	37.41%	37.61%	-33.77%
LONG-TERM LIABILITIES
Long-Term Debt	$128.7M	$127.4M	$125.3M
YoY Change	3.11%	1.63%	10.61%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$128.7M	$127.4M	$125.3M
YoY Change	3.11%	1.63%	9.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.61M	$21.24M	$15.44M
Total Long-Term Liabilities	$128.7M	$127.4M	$125.3M
Total Liabilities	$152.3M	$148.6M	$140.8M
YoY Change	7.26%	5.58%	2.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$112.7M	-$109.9M	-$93.85M
YoY Change	18.77%	17.05%
Common Stock	$2.092M	$2.092M	$2.092M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$110.6M	-$107.8M	-$91.76M
YoY Change
Total Liabilities & Shareholders Equity	$41.66M	$40.86M	$49.01M
YoY Change	-15.27%	-16.63%	-2.9%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$2.871M	-$2.566M	-$1.320M
YoY Change	171.62%	94.39%	37.5%
Depreciation, Depletion And Amortization	$860.0K	$842.0K	$716.0K
YoY Change	24.1%	17.6%	22.6%
Cash From Operating Activities	$30.00K	-$1.913M	-$1.297M
YoY Change	-94.67%	47.49%	-63.36%
INVESTING ACTIVITIES
Capital Expenditures	$731.0K	$1.159M	$1.050M
YoY Change	-49.55%	10.38%	-202.54%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$731.0K	-$1.159M	-$1.050M
YoY Change	-49.55%	10.38%	2.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.442M	544.0K	-550.0K
YoY Change	-437.7%	-198.91%	-121.65%
NET CHANGE
Cash From Operating Activities	30.00K	-1.913M	-1.297M
Cash From Investing Activities	-731.0K	-1.159M	-1.050M
Cash From Financing Activities	1.442M	544.0K	-550.0K
Net Change In Cash	741.0K	-2.528M	-2.897M
YoY Change	-156.44%	-12.74%	43.2%
FREE CASH FLOW
Cash From Operating Activities	$30.00K	-$1.913M	-$1.297M
Capital Expenditures	$731.0K	$1.159M	$1.050M
Free Cash Flow	-$701.0K	-$3.072M	-$2.347M
YoY Change	-20.88%	30.89%	-6.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0000079661
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities		usd
	PRSI	Increase Decrease In Due To Securities Broker IncreaseDecreaseInDueToSecuritiesBroker		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q4	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments		usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments		usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent		usd
CY2023Q4	us-gaap	Security Deposit Liability SecurityDepositLiability		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-4057
	dei	Entity Registrant Name EntityRegistrantName	PORTSMOUTH SQUARE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-1674111
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1516 S. Bundy Dr.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90025
	dei	City Area Code CityAreaCode	(310)
	dei	Local Phone Number LocalPhoneNumber	889-2500
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	734187	shares
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	34638000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	34381000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	325000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	359000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3668000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2295000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	800000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	2911000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	447000	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	419000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	979000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	735000	usd
CY2023Q4	us-gaap	Assets Assets	40857000	usd
CY2023Q2	us-gaap	Assets Assets	41100000	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2671000	usd
CY2023Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2954000	usd
CY2023Q4	PRSI	Mortgage Notes Payable MortgageNotesPayable	106503000	usd
CY2023Q2	PRSI	Mortgage Notes Payable MortgageNotesPayable	107117000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	148618000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	144735000	usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	734187	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	734187	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	734187	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	734187	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2092000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2092000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109853000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-105727000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-107761000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-103635000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40857000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41100000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10225000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9892000	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9405000	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8726000	usd
CY2023Q4	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	841000	usd
CY2022Q4	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	635000	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	434000	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	517000	usd
CY2023Q4	us-gaap	Costs And Expenses CostsAndExpenses	10680000	usd
CY2022Q4	us-gaap	Costs And Expenses CostsAndExpenses	9878000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-455000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	14000	usd
CY2023Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1599000	usd
CY2022Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1655000	usd
CY2023Q4	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	54000	usd
CY2022Q4	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	107000	usd
CY2023Q4	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3000	usd
CY2022Q4	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	6000	usd
CY2023Q4	PRSI	Trading And Margin Interest Expense TradingAndMarginInterestExpense	44000	usd
CY2022Q4	PRSI	Trading And Margin Interest Expense TradingAndMarginInterestExpense	81000	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2111000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2052000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2566000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2038000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-718000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-2566000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-1320000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.50
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.50
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.80
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.80
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	734187	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	734187	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	734187	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	734187	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21318000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22202000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18686000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18032000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1662000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1262000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	753000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	826000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	21101000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	20120000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	217000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2082000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3205000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3287000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-34000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	97000	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	6000	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	32000	usd
	PRSI	Trading And Margin Interest Expense TradingAndMarginInterestExpense	82000	usd
	PRSI	Trading And Margin Interest Expense TradingAndMarginInterestExpense	115000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4342000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4132000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4125000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2050000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-721000	usd
	us-gaap	Profit Loss ProfitLoss	-4126000	usd
	us-gaap	Profit Loss ProfitLoss	-1329000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.81
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.81
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	734187	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	734187	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	734187	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	734187	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-103635000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1560000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-105195000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-2566000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-107761000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-90432000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-9000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-90441000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-90441000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1320000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-91761000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-91761000	usd
	us-gaap	Profit Loss ProfitLoss	-4126000	usd
	us-gaap	Profit Loss ProfitLoss	-1329000	usd
	PRSI	Marketable Securities Unrealized Gain Loss Including Gain Loss On Common Stock MarketableSecuritiesUnrealizedGainLossIncludingGainLossOnCommonStock	-34000	usd
	PRSI	Marketable Securities Unrealized Gain Loss Including Gain Loss On Common Stock MarketableSecuritiesUnrealizedGainLossIncludingGainLossOnCommonStock	234000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1662000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1262000	usd
	PRSI	Amortization Of Loan Costs AmortizationOfLoanCosts	122000	usd
	PRSI	Amortization Of Loan Costs AmortizationOfLoanCosts	122000	usd
	PRSI	Amortization Of Other Notes Payable AmortizationOfOtherNotesPayable	283000	usd
	PRSI	Amortization Of Other Notes Payable AmortizationOfOtherNotesPayable	283000	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-473000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-53000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	244000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	946000	usd
	PRSI	Increase Decrease In Accounts Payable And Other Liabilities IncreaseDecreaseInAccountsPayableAndOtherLiabilities	269000	usd
	PRSI	Increase Decrease In Accounts Payable And Other Liabilities IncreaseDecreaseInAccountsPayableAndOtherLiabilities	1617000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	53000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-130000	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	1958000	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	501000	usd
	PRSI	Increase Decrease In Due To Securities Broker IncreaseDecreaseInDueToSecuritiesBroker	-130000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-583000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	976000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1919000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2682000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1919000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2682000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2500000	usd
	PRSI	Payment Of Mortgage And Finance Leases Net PaymentOfMortgageAndFinanceLeasesNet	736000	usd
	PRSI	Payment Of Mortgage And Finance Leases Net PaymentOfMortgageAndFinanceLeasesNet	1162000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1764000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1162000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-738000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2868000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5206000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8888000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4468000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6020000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3205000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3288000	usd
CY2017Q1	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	automatically renews for successive one (1) year periods, not to exceed five years in the aggregate, subject to certain conditions
CY2017Q1	PRSI	Percentage Of Management Fee Payable PercentageOfManagementFeePayable	0.0170	pure
CY2017Q1	PRSI	Percentage Of Gross Operating Profit PercentageOfGrossOperatingProfit	0.10	pure
CY2023Q4	PRSI	Mortgage Notes Payable MortgageNotesPayable	106503000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109853000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-583000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3668000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2295000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	800000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	2911000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	325000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	359000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2500000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10225000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9892000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21318000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22202000	usd
CY2023Q4	PRSI	Contract Assets Other Than Trade And Other Receivables ContractAssetsOtherThanTradeAndOtherReceivables	0	usd
CY2023Q2	PRSI	Contract Assets Other Than Trade And Other Receivables ContractAssetsOtherThanTradeAndOtherReceivables	1000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	290000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	203000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	493000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	493000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1828000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	99849000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	65211000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	34638000	usd
CY2023Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	97929000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	63548000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	34381000	usd
	us-gaap	Depreciation Depreciation	1662000	usd
	us-gaap	Depreciation Depreciation	1262000	usd
CY2022Q4	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-37000	usd
CY2023Q4	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	54000	usd
CY2022Q4	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	144000	usd
CY2023Q4	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	54000	usd
CY2022Q4	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	107000	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-137000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-34000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	234000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-34000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	97000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3668000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2295000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	800000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	2911000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4468000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5206000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segments
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10225000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	-9839000	usd
CY2023Q4	PRSI	Segment Operating Income Loss SegmentOperatingIncomeLoss	386000	usd
CY2023Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1599000	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	841000	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	13000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-2566000	usd
CY2023Q4	us-gaap	Assets Assets	40857000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9892000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	9243000	usd
CY2022Q4	PRSI	Segment Operating Income Loss SegmentOperatingIncomeLoss	649000	usd
CY2022Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1655000	usd
CY2022Q4	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	635000	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	32000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-718000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1320000	usd
CY2022Q4	us-gaap	Assets Assets	49005000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21318000	usd
	us-gaap	Operating Expenses OperatingExpenses	19439000	usd
	PRSI	Segment Operating Income Loss SegmentOperatingIncomeLoss	1879000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3205000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	1662000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-110000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4126000	usd
CY2023Q4	us-gaap	Assets Assets	40857000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22202000	usd
	us-gaap	Operating Expenses OperatingExpenses	18858000	usd
	PRSI	Segment Operating Income Loss SegmentOperatingIncomeLoss	3344000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3287000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	1262000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	14000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-721000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1329000	usd
CY2022Q4	us-gaap	Assets Assets	49005000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2500000	usd
CY2017Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10Y
CY2017Q1	PRSI	Key Money Incentive Advance To Related Party KeyMoneyIncentiveAdvanceToRelatedParty	2000000	usd
CY2017Q1	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P8Y
CY2017Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05275	pure
CY2017Q1	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	Beginning in February 2017, the loan began to amortize over a thirty-year period through its maturity date of January 2024.
CY2023Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	86503000	usd
CY2023Q2	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	87240000	usd
	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The mezzanine loan is secured by the Operating membership interest held by Mezzanine and is subordinated to the Mortgage Loan. The mezzanine interest only loan had an interest rate of 9.75% per annum and a maturity date of January 1, 2024.
CY2023Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	2830000	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	1235000	usd
CY2023Q4	PRSI	Advance Deposits AdvanceDeposits	535000	usd
CY2023Q2	PRSI	Advance Deposits AdvanceDeposits	301000	usd
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	59000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3101000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	2863000	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	2189000	usd
CY2023Q2	us-gaap	Management Fee Payable ManagementFeePayable	1683000	usd
CY2023Q4	PRSI	Mortgage Interest Payable MortgageInterestPayable	518000	usd
CY2023Q2	PRSI	Mortgage Interest Payable MortgageInterestPayable	1580000	usd
CY2023Q4	PRSI	Withholding And Other Taxes Payable WithholdingAndOtherTaxesPayable	1202000	usd
CY2023Q2	PRSI	Withholding And Other Taxes Payable WithholdingAndOtherTaxesPayable	1204000	usd
CY2023Q2	us-gaap	Security Deposit Liability SecurityDepositLiability	52000	usd
CY2023Q4	PRSI	Franchise Fee Payable FranchiseFeePayable	1375000	usd
CY2023Q2	PRSI	Franchise Fee Payable FranchiseFeePayable	2510000	usd
CY2023Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	253000	usd
CY2023Q2	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	194000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	12003000	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	11681000	usd

Files In Submission

Name	View Source	Status
0001493152-24-006479-index-headers.html	Edgar Link	pending
0001493152-24-006479-index.html	Edgar Link	pending
0001493152-24-006479.txt	Edgar Link	pending
0001493152-24-006479-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prsi-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
prsi-20231231_cal.xml	Edgar Link	unprocessable
prsi-20231231_def.xml	Edgar Link	unprocessable
prsi-20231231_lab.xml	Edgar Link	unprocessable
prsi-20231231_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRSI
PORTSMOUTH SQUARE INC Stock $prsi

2024 Q1 Form 10-Q Financial Statement

#000149315224006479 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRSI PORTSMOUTH SQUARE INC Stock $prsi

2024 Q1 Form 10-Q Financial Statement

#000149315224006479 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRSI
PORTSMOUTH SQUARE INC Stock $prsi